Lin Xie
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Regulatory B Cells in Tumor Microenvironment.
Journal: Current issues in molecular biology
Published: December 16, 2025
Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis.
Journal: Precision clinical medicine
Published: March 02, 2024
Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis.
Journal: Scientific reports
Published: May 29, 2023
Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
Journal: Investigational new drugs
Published: October 21, 2021
Implication of myeloid differentiation factor 88 inhibitor TJ-M2010-5 for therapeutic intervention of hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 04, 2018
Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.
Journal: Metabolism: clinical and experimental
Published: December 28, 2015
Insulin-like growth factor I promotes oocyte maturation through increasing the expression and phosphorylation of epidermal growth factor receptor in the zebrafish ovary.
Journal: Molecular and cellular endocrinology
Published: July 07, 2015
Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
Journal: Journal of the National Cancer Institute
Published: November 21, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026